LAD603
/ Almirall
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
April 30, 2026
A Study of LAD603 in Adults With Alopecia Areata
(clinicaltrials.gov)
- P2 | N=136 | Recruiting | Sponsor: Almirall, S.A.
Trial initiation date • Alopecia • Dermatology • Immunology
April 30, 2026
A Study of LAD603 in Adults With Alopecia Areata
(clinicaltrials.gov)
- P2 | N=118 | Recruiting | Sponsor: Almirall, S.A. | N=70 ➔ 118
Enrollment change • Alopecia • Dermatology • Immunology
April 02, 2026
A Study of LAD603 in Adults With Alopecia Areata
(clinicaltrials.gov)
- P2 | N=118 | Recruiting | Sponsor: Almirall, S.A.
New P2 trial • Alopecia • Dermatology • Immunology
March 26, 2026
M-00223-20: Dose-finding study of LAD603 in adults with alopecia areata
(clinicaltrialsregister.eu)
- P1/2 | N=70 | Not yet recruiting | Sponsor: Almirall S.A.
New P1/2 trial • Alopecia • Dermatology • Immunology
January 29, 2026
A Study of LAD603 in Adults With Alopecia Areata
(clinicaltrials.gov)
- P2 | N=136 | Recruiting | Sponsor: Almirall, S.A. | Trial primary completion date: Sep 2027 ➔ May 2027
Trial primary completion date • Alopecia • Dermatology • Immunology
January 01, 2026
A Study of LAD603 in Adults With Alopecia Areata
(clinicaltrials.gov)
- P2 | N=136 | Recruiting | Sponsor: Almirall, S.A.
New P2 trial • Alopecia • Dermatology • Immunology
1 to 6
Of
6
Go to page
1